145 results on '"Ardern-Jones, M"'
Search Results
2. Mapping exercise and status update of eight established registries within the TREatment of ATopic eczema (TREAT) Registry Taskforce
3. Methods for the analysis of skin microbiomes: a comparison of sampling processes and 16S rRNA hypervariable regions
4. 310 Efficacy and safety of abrocitinib in biologic-exposed versus biologic-naïve patients with moderate-to-severe atopic dermatitis
5. STAT4 expression and activation is increased during mitosis in vitro and in vivo in skin‐ and mucosa‐derived cell types: implications in neoplastic and inflammatory skin diseases
6. Mapping exercise and status update of eight established registries within the TREatment of ATopic eczema (TREAT) Registry Taskforce
7. U.K. guidelines for the management of Stevens–Johnson syndrome/toxic epidermal necrolysis in adults 2016
8. Limited exposure to ambient ultraviolet radiation and 25-hydroxyvitamin D levels: a systematic review*
9. An updated report on the incidence and epidemiological trends of keratinocyte cancers in the United Kingdom 2013–2018
10. Treatment outcomes of patients with Atopic Dermatitis (AD) treated with dupilumab through the Early Access to Medicines Scheme (EAMS) in the UK
11. Biomarkers in atopic dermatitis: it is time to stratify
12. Primary cutaneous nodular amyloidosis associated with psoriasis
13. Presence of the HLA-A*3101 allele in a familial case of drug reaction with eosinophilia and systemic symptoms, secondary to carbamazepine
14. New recommendations for retinal monitoring in hydroxychloroquine users: baseline testing is no longer supported
15. Supportive care in the acute phase of Stevens–Johnson syndrome and toxic epidermal necrolysis: an international, multidisciplinary Delphi‐based consensus
16. In vitro diagnostic assays are effective during the acute phase of delayed-type drug hypersensitivity reactions
17. Atypical erythema multiforme is a prognostic indicator of severe hepatic dysfunction in Dress (Drug Reaction with Eosinophilia and Systemic Symptoms)
18. Atopic Dermatitis
19. Human primary cutaneous squamous cell carcinomas contain regulatory T-cells which suppress peritumoral effector T-cell immune responses: RF07
20. Superior activation of CD8+ lymphocytes by primary human Langerhans cells is CD70 dependent: o-11
21. The peritumoral infiltrate of human cutaneous squamous cell carcinomas contains regulatory T cells which suppress peritumoral effector T-lymphocyte function: o-12
22. Nonuraemic calciphylaxis: CPC-5
23. Frontal fibrosing alopecia: a descriptive cross‐sectional study of 711 cases in female patients from the UK
24. Filaggrin null mutations associate with increased frequencies of allergen-specific CD4+ T-helper 2 cells in patients with atopic eczema
25. Repeated low-dose skin exposure is an effective sensitizing stimulus, a factor to be taken into account in predicting sensitization risk
26. Identification of an immunodominant region of Fel d 1 and characterization of constituent epitopes
27. Anti-lymphocyte function associated antigen-1 inhibits T-helper 2 function of human allergen-specific CD4+ T cells
28. Genome-wide association study in frontal fibrosing alopecia identifies four susceptibility loci including HLA-B*07:02
29. Dose-related reduction in allergen-specific T cells associates with clinical response of atopic dermatitis to methotrexate
30. Superantigen-allergen synergy: a novel mechanism of cutaneous atopic disease: R-1
31. Frontal fibrosing alopecia: a descriptive cross-sectional study of 711 cases in female patients from the UK
32. Identification of Fel d 1 specific CD8+ T cells in cat allergic patients: 6.10
33. Two cases of cutaneous osteosarcoma
34. Patch testing with Lyral®: 1 yearʼs experience in the U.K.
35. Widespread morphoea following radiotherapy for carcinoma of the breast
36. Giant condyloma of Buschke–Loewenstein in association with erythroderma
37. Medilan TM—reduced incidence of contact dermatitis compared with lanolin
38. Widespread bullous eruption due to multiple bed bug bites
39. Bronchiolitis obliterans as a long‐term sequela of Stevens–Johnson syndrome and toxic epidermal necrolysis in children
40. Accidental re‐exposure causing repeated severe acute generalized exanthematous pustulosis
41. Treatment outcomes of patients with Atopic Dermatitis (AD) treated with dupilumab through the Early Access to Medicines Scheme (EAMS) in the UK.
42. Genome-wide association study in frontal fibrosing alopecia identifies four susceptibility loci including HLA-B*07:02
43. SJS/TEN 2017: Building multidisciplinary networks to drive science and translation
44. STAT4 expression and activation is increased during mitosisin vitroandin vivoin skin- and mucosa-derived cell types: implications in neoplastic and inflammatory skin diseases
45. Myaesthenia gravis exacerbation caused by axillary injection of botulinum toxin A for treatment of hyperhidrosis
46. The role of human keratinocytes in T-cell activation
47. Repeated low-dose skin exposure is an effective sensitizing stimulus, a factor to be taken into account in predicting sensitization risk
48. Patch testing in drug allergy.
49. Convergent evolution of monocyte differentiation in adult skin instructs Langerhans cell identity.
50. Management of Adult Patients With Drug Reaction With Eosinophilia and Systemic Symptoms: A Delphi-Based International Consensus.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.